Actinogen Medical Ltd ACW

Trading Information

Previous Close Price
A$0.01
Day Range
A$0.01–0.01
52-Week Range
A$0.01–0.07
Bid/Ask
A$0.01 / A$0.01
Shares Outstanding
3.87B
Market Cap
A$34.83M
Volume/Avg
54M / 10M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
—

Valuation

Metric
ACW
Price/Earnings (Normalized)
—
Price/Book Value
1.39
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
ACW
Quick Ratio
3.44
Current Ratio
3.45
Interest Coverage
—
Quick Ratio
ACW

Profitability

Metric
ACW
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
ACW

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|MMF%^BLOCK|yk&$n$132B
Regeneron Pharmaceuticals Inc
REGN
LOCK|jH<b<#LOCK|@?%VC$96B
Moderna Inc
MRNA
LOCK|Zw$FB%LOCK|>>$81B
argenx SE ADR
ARGX
LOCK|$cQ!@G<LOCK|gY!$59B
BeOne Medicines Ltd ADR
ONC
LOCK|$%#dt#^LOCK|&sH$47B
Royalty Pharma PLC Class A
RPRX
LOCK|JT#>#^lLOCK|%^?$$30B
Incyte Corp
INCY
LOCK|&<M<<s?LOCK|JdS$24B
BioNTech SE ADR
BNTX
LOCK|#F^>@!tLOCK|@%$20B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|?gm$T?GLOCK|WDwt$20B
BridgeBio Pharma Inc
BBIO
LOCK|wQ%$k&#LOCK|T#!$15B

Sponsor Center